Evidence to support the use of melatonin to reduce the duration or severity of jet lag remains “inconclusive and conflicting” despite decades on the market, according to a new review.

Writing in the BMJ’s Drug and Therapeutics Bulletin, UK researchers suggest that doctors should avoid prescribing the hormone to patients suffering from jet lag, which they say is a short-term, self-limiting ailment.